Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain

Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain

For the treatment of neurological diseases, achieving sufficient exposure to the brain parenchyma is a critical determinant of drug efficacy. The blood–brain barrier (BBB) functions to tightly control the passage of substances between the bloodstream and the central nervous system, and as such poses...

Full description

Bibliographic Details
Main Authors:	Rinie Bajracharya, Alayna C. Caruso, Laura J. Vella, Rebecca M. Nisbet
Format:	Article
Language:	English
Published:	MDPI AG 2021-11-01
Series:	Pharmaceutics
Subjects:	blood–brain barrier neurological disease antibodies monoclonal antibodies biotherapeutics focused ultrasound
Online Access:	https://www.mdpi.com/1999-4923/13/12/2014

Similar Items

Challenges and Strategies for a Thorough Characterization of Antibody Acidic Charge Variants
by: Y. Diana Liu, et al.
Published: (2022-11-01)

Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans
by: Hans Peter Grimm, et al.
Published: (2023-12-01)

Design of antibody variable fragments with reduced reactivity to preexisting anti-drug antibodies
by: Maria U. Johansson, et al.
Published: (2023-12-01)

Antibodies for the Treatment of Brain Metastases, a Dream or a Reality?
by: Marco Cavaco, et al.
Published: (2020-01-01)

Anti-Drug Antibodies: Emerging Approaches to Predict, Reduce or Reverse Biotherapeutic Immunogenicity
by: Kathleen P. Pratt
Published: (2018-05-01)

Breaking barriers: exploring mechanisms behind opening the blood–brain barrier
by: Melanie E. M. Stamp, et al.
Published: (2023-11-01)

Preclinical Research on Focused Ultrasound-Mediated Blood–Brain Barrier Opening for Neurological Disorders: A Review
by: Chanho Kong, et al.
Published: (2023-02-01)

Identification of tyrosine sulfation in the variable region of a bispecific antibody and its effect on stability and biological activity
by: Christopher B. Lietz, et al.
Published: (2023-12-01)

Current and emerging monoclonal antibodies, antibody-drug conjugates, and bispecific antibodies in treatment of lymphoma
by: Suheil Albert Atallah-Yunes, et al.
Published: (2022-01-01)

Current trends in monoclonal antibody development and manufacturing /
by: Shire, Steven J.
Published: (2010)

Large-scale production of monoclonal antibodies in suspension culture /
by: 271860 Backer, M. P., et al.

Neutralizing anti-interleukin-1β antibodies modulate fetal blood–brain barrier function after ischemia
by: Xiaodi Chen, et al.
Published: (2015-01-01)

Trends in industrialization of biotherapeutics: a survey of product characteristics of 89 antibody-based biotherapeutics
by: Kyle P. Martin, et al.
Published: (2023-12-01)

Improving In Vivo Brain Delivery of Monoclonal Antibody Using Novel Cyclic Peptides
by: Kavisha R. Ulapane, et al.
Published: (2019-10-01)

Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)

Charge and hydrophobicity are key features in sequence-trained machine learning models for predicting the biophysical properties of clinical-stage antibodies
by: Max Hebditch, et al.
Published: (2019-12-01)

Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor
by: William M. Pardridge, et al.
Published: (2021-06-01)

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
by: Ana Antunes, et al.
Published: (2023-12-01)

Process scale purification of antibodies /
by: Gottschalk, Uwe
Published: (2009)

Principles and Current Clinical Landscape of Multispecific Antibodies against Cancer
by: Mariam Elshiaty, et al.
Published: (2021-05-01)

Reduction of αSYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody
by: Sahar Roshanbin, et al.
Published: (2022-07-01)

Immune- and Non-Immune-Mediated Adverse Effects of Monoclonal Antibody Therapy: A Survey of 110 Approved Antibodies
by: Brian A. Baldo
Published: (2022-02-01)

Immunological Detection of Rabies Virus in Brain Tissues of Infected Dogs by Monoclonal Antibodies
by: Nyoman Mantik Astawa, et al.
Published: (2010-12-01)

Increasing the Therapeutic Efficacy of Extracellular Vesicles From the Antigen-Specific Antibody and Light Chain Perspective
by: Katarzyna Nazimek, et al.
Published: (2021-11-01)

Kinetics of Blood–Brain Barrier Transport of Monoclonal Antibodies Targeting the Insulin Receptor and the Transferrin Receptor
by: William M. Pardridge
Published: (2021-12-01)

Investigating brain uptake of a non-targeting monoclonal antibody after intravenous and intracerebroventricular administration
by: Arthur J. Van De Vyver, et al.
Published: (2022-08-01)

Modelling a Human Blood-Brain Barrier Co-Culture Using an Ultrathin Silicon Nitride Membrane-Based Microfluidic Device
by: Diana Hudecz, et al.
Published: (2023-03-01)

Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992)

Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion
by: Yoshiyuki Arata, et al.
Published: (2023-12-01)

AAV Vector-Mediated Antibody Delivery (A-MAD) in the Central Nervous System
by: Marika Marino, et al.
Published: (2022-04-01)

Recombinant antibodies for immunotherapy /
by: Little, Melvyn
Published: (2009)

Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments
by: Mehdi Arbabi-Ghahroudi
Published: (2022-04-01)

Acute and Chronic Dosing of a High-Affinity Rat/Mouse Chimeric Transferrin Receptor Antibody in Mice
by: Demi M. Castellanos, et al.
Published: (2020-09-01)

Monoclonal antibodies : principles and practice : production and application of monoclonal antibodies in cell biology, biochemistry and immunology /
by: 250151 Goding, James W.
Published: (1996)

Focused Ultrasound Enhances Brain Delivery of Sorafenib Nanoparticles
by: Daniel Dahis, et al.
Published: (2023-02-01)

Focused Ultrasound-Mediated Delivery of Anti-Programmed Cell Death-Ligand 1 Antibody to the Brain of a Porcine Model
by: Siaka Fadera, et al.
Published: (2023-10-01)

Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
by: Leonardo F. Ormundo, et al.
Published: (2023-10-01)

Development of antibody-based therapeutics : translational considerations /
by: Tabrizi, Mohammad A., et al.
Published: (c201)

Bispecific antibodies: design, therapy, perspectives
by: Sedykh SE, et al.
Published: (2018-01-01)

Catalytic antibodies /
by: Keinan, Ehud
Published: (2005)